DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2021年6月08日 (火) 午後 7:00 - 2021年6月11日 (金) 午前 12:00

(Central Europe Standard Time)

4051 Basel, Switzerland

Future of Evidence and Smart Health Conference

Leveraging RWE to advance healthcare decision-making.

Session 3: Data Sources

Session Chair(s)

Michael  Lees, MA

Michael Lees, MA

Chief Operating Officer and Head of Market Access Strategy

PHMR Ltd, United Kingdom

As the importance of real world evidence to healthcare decision makers continues to grow, so do the questions addressed by real world evidence and the sources of such evidence. In addition to the various sources of claims data and data from health records in North America, EU and Asia, the number of registries developed to shed further light on disease management, outcomes and real world effectiveness continues to grow, while data captured from less traditional sources such as early access programs and social media is also increasingly used. This session aims to identify the emerging trends when making the choice about the most appropriate choices for the sources of real world evidence from the perspective of HTA bodies, real world evidence practitioners and pharmaceutical industry.

Speaker(s)

Cormac  Sammon, PHD

Insights from a RWE Practitioner

Cormac Sammon, PHD

PHMR, United Kingdom

Chief Epidemiologist and Head of RWE

Antonia Electra Panayi, PHD, MSC

The Industry (Medical Affairs) Perspective

Antonia Electra Panayi, PHD, MSC

Takeda, United States

Head, Global Medical Evidence

Amr  Makady, PHARMD, PHD, MSC

The Access Perspective

Amr Makady, PHARMD, PHD, MSC

Johnson & Johnson, Netherlands

Health Economics and Market Access Manager

Michael  Lees, MA

Panel Discussion with Q&A, Moderated by:

Michael Lees, MA

PHMR Ltd, United Kingdom

Chief Operating Officer and Head of Market Access Strategy

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。